Register
Forgot your password?

Transannular plastic surgery for radical correction of Fallot’s tetrad – what is next?

Authors: Lyapin A.A., Tarasov R.S.

Company: Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2025-19-2-146-154

For citation: Lyapin A. A., Tarasov R.S. Transannular plastic surgery for radical correction of Fallot’s tetrad – what is next? Creative Cardiology. 2025; 19 (2): 146–154 (in Russ.). DOI: 10.24022/1997-3187-2025-19-2-146-154

Received / Accepted:  24.03.2025 / 28.03.2025

Keywords: Fallot’s tetrad transannular plastic regurgitation on the pulmonary artery valve



Subscribe 🔒

 

Abstract

This review analyzes the current world literature on the identified problem of pulmonary artery valve insufficiency in a child who underwent radical correction of Fallot’s tetrade with transanular plastic surgery. The review assessed modern approaches to diagnosis and treatment of this cohort of patients, considered the main complications, the dynamics of the patients’ condition after the intervention, and the long-term prognosis. An analysis of the literature was conducted for the period from 2017 to 2024. The main databases used to search for information and write the review: e-library, National library of medicine, Pubmed.gov, Nature platform, Springer materials platform, PLOS (Public Library of Science).

References

  1. Lyapin A.A., Tarasov R.S. Modern data on correction of tetralogy of Fallot. Russian Journal of Cardiology and Cardiovascular Surgery. 2021; 14 (5): 349–353 (in Russ.) DOI: 10.17116/kardio20211405134
  2. van der Ven J.P.G., van den Bosch E., Bogers A.J.C.C., Helbing W.A. Current outcomes and treatment of tetralogy of Fallot. F1000 Faculty. 2019; 8: F1000. DOI: 10.12688/f1000research.17174.1
  3. Kochav J., DeFariah Y.D., Bhatt A. Adult congenital heart disease in clinical practice. Tetralogy of Fallot New York, NY. Springer Berlin Heidelberg. 2018; 23: 295–318. DOI: 10.21037/atm.2020.02.18
  4. Cotella J.I., Kovacs A., Addetia K., Fabian A., Asch F.M., Lang R.M.; WASE Investigators. Three-dimensional echocardiographic evaluation of longitudinal and non-longitudinal components of right ventricular contraction: results from the World Alliance of Societies of Echocardiography study. Eur. Heart J. Cardiovasc. Imaging. 2024; 25 (2): 152–160. DOI: 10.1093/ehjci/jead213
  5. Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur. Heart J. 2021; 42 (6): 563–645. DOI: 10.1093/eurheartj/ehaa554
  6. Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A. et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocardiogr. 2017; 30 (4): 303–371. DOI: 10.1016/j.echo.2017.01.007
  7. Koestenberger M., Nagel B., Ravekes W., Everett A.D., Stueger H.P., Heinzl B. et al. Tricuspid annular plane systolic excursion and right ventricular ejection fraction in pediatric and adolescent patients with tetralogy of Fallot, patients with atrial septal defect, and age-matched normal subjects. Clin. Res. Cardiol. 2011; 100 (1): 67–75. DOI: 10.1007/s00392-010-0213-z
  8. Sánchez Ramírez C.J., Pérez de Isla L. Tetralogy of Fallot: cardiac imaging evaluation. Ann. Translat. Med. 2020; 8 (15): 966. DOI: 10.21037/atm.2020.02.18
  9. Shiina Y., Taniguchi K., Nagao M., Takahashi T., Niwa K., Kawakubo M., Inai K. The relationship between extracellular volume fraction in symptomatic adults with tetralogy of Fallot and adverse cardiac events. J. Cardiol. 2020; 75 (4): 424–431. DOI: 10.1016/j.jjcc.2019.09.009
  10. Lapierre C., Dubois J., Rypens F., Raboisson M.J., Déry J. Tetralogy of Fallot: Preoperative assessment with MR and CT imaging. Diagn. Interv. Imaging. 2016; 97 (5): 531–541. DOI: 10.1016/j.diii.2016.01.009
  11. Sandeep B., Huang X., Xu F., Su P., Wang T., Sun X. Etiology of right ventricular restrictive physiology early after repair of tetralogy of Fallot in pediatric patients. J. Cardiothorac. Surg. 2019; 14 (1): 84. DOI: 10.1186/s13019-019-0909-8
  12. Mercer-Rosa L., Fogel M.A., Paridon S.M., Rychik J., Yang W., Goldmuntz E. Revisiting the end-diastolic forward flow (restrictive physiology) in tetralogy of Fallot: an exercise, echocardiographic, and magnetic resonance study. JACC Cardiovasc. Imaging. 2018; 11 (10): 1547–1548. DOI: 10.1016/j.jcmg.2018.01.008
  13. Egbe A.C., Bonnichsen C., Reddy Y.N.V., Anderson J.H., Borlaug B.A. Pathophysiologic and prognostic implications of right atrial hypertension in adults with tetralogy of Fallot. J. Am. Heart Assoc. 2019; 8 (22): e014148. DOI: 10.1161/JAHA.119.014148
  14. Egbe A.C., Pellikka P.A., Miranda W.R., Bonnichsen C., Reddy Y.N.V., Borlaug B.A., Connolly H.M. Echocardiographic predictors of severe right ventricular diastolic dysfunction in tetralogy of Fallot: Relations to patient outcomes. Int. J. Cardiol. 2020; 306: 49–55. DOI: 10.1016/j.ijcard.2020.02.067
  15. Dobbels B., Herregods M.C., Troost E., Van De Bruaene A., Rega F., Budts W., De Meester P. Early versus late pulmonary valve replacement in patients with transannular patch-repaired Tetralogy of Fallot. Interac. Cardiovasc. Thorac. Surg. 2017; 25: 427–433. DOI: 10.1093/icvts/ivx118
  16. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013; 128: 1855–1857. DOI: 10.1161/CIRCULATIONAHA.113.005878
  17. Kitagawa A., Oka N., Kimura S., Ando H., Honda T., Takanashi M. et al. Clinical utility of the plasma brain natriuretic peptide level in monitoring tetralogy of Fallot patients over the long term after initial intracardiac repair: considerations for pulmonary valve replacement. Pediatr. Cardiol. 2015; 36 (4): 752–758. DOI: 10.1007/s00246-014-1075-3
  18. Lim C., Lee J.Y., Kim W.H., Kim S.C., Song J.Y., Kim S.J. et al. Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur. J. Cardiothorac. Surg. 2004; 25 (5): 728–734. DOI: 10.1016/j.ejcts.2004.01.036
  19. Borowski A., Ghodsizad A., Litmathe J., Lawrenz W., Schmidt K.G., Gams E. Pediatr Cardiol. Severe pulmonary regurgitation late after total repair of tetralogy of Fallot: surgical considerations. Pediatr. Cardiol. 2004; 25 (5): 466–471. DOI: 10.1007/s00246-003-0579-z
  20. Romeo J.L.R., Takkenberg J.J.M., Cuypers J.A.A.E., de Groot N.M.S., van de Woestijne P., Bruining N. et al. Timing of pulmonary valve replacement in patients with corrected Fallot to prevent QRS prolongation. Eur. J. Cardiothorac. Surg. 2020; 58 (3): 559–566. DOI: 10.1093/ejcts/ezaa049
  21. Herrmann J.L., Brown J.W. Seven decades of valved right ventricular outflow tract reconstruction. The most common heart procedure in children. J. Thorac. Cardiovasc. Surg. 2020; 160: 1284–1288. DOI: 10.1016/j.jtcvs.2020.04.137
  22. Said S.M. Inspiris resilia early failure in the pulmonary position: is it the technique or the valve? Ann. Thorac. Surg. 2023: 116 (3): 651–652. DOI: 10.1016/j.athoracsur.2023.02.051
  23. Mongeon F.P., Ben Ali W., Khairy P., Bouhout I., Therrien J., Wald R.M. et al. Pulmonary valve replacement for pulmonary regurgitation in adults with tetralogy of Fallot: a meta-analysis-a report for the Writing Committee of the 2019 Update of the Canadian Cardiovascular Society Guidelines for the Management of adults with congenital heart disease. Can. J. Cardiol. 2019; 35 (12): 1772–1783. DOI: 10.1016/j.cjca.2019.08.031
  24. Valente A.M., Gauvreau K., Assenza G.E., Babu-Narayan S.V., Evans S.P., Gatzoulis M. et al. Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort. Pediatr. Cardiol. 2013; 34 (1): 95–104. DOI: 10.1007/s00246-012-0394-5
  25. Slouha E., Trygg G., Tariq A.H., La A., Shay A., Gorantla V.R. Pulmonary valve replacement timing following initial tetralogy of Fallot repair: a systematic review. Cureus. 2023; 15 (11): e49577. DOI: 10.7759/cureus.49577
  26. Podzolkov V.P., Yurlov I.A., Danilov T.Yu., Gadzhiyev A.A., Hasan A., Kovalev D.V., et al. Pulmonary arterial valve replacement in the late periods after radical correction of congenital heart disease with pulmonary blood flow obstruction. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2008; 4: 4–11 (in Russ.).
  27. Carrel T. Past, present, and future options for right ventricular outflow tract reconstruction. Front. Surg. 2023; 10: 1185324. DOI: 10.3389/fsurg.2023.1185324
  28. Schoenhoff F.S., Loup O., Gahl B., Banz Y., Pavlovic M., Pfammatter J.P., et al. The Contegra bovine jugular vein graft versus the Shelhigh pulmonic porcine graft for reconstruction of the right ventricular outflow tract: a comparative study. J. Thorac. Cardiovasc. Surg. 2011; 141: 654–661. DOI: 10.1016/j.jtcvs.2010.06.068
  29. Al Mosa A.F.H., Madathil S., Bernier P.L., Tchervenkov C. Long-Term outcome following pulmonary valve replacement in repaired tetralogy of Fallot. World J. Pediatr. Congenit. Heart Surg. 2021; 12 (5): 616–627. DOI: 10.1177/21501351211027857
  30. Christenson J.T., Vala D., Sierra J., Beghetti M., Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J. Thorac. Cardiovasc. Surg. 2004; 127: 242–250. DOI: 10.1016/j.jtcvs.2003.07.047
  31. Oeser C., Uyanik-Uenal K., Kocher A., Laufer G., Andreas M. Long-term performance of pulmonary homografts after the ross procedure: experience up to 25 years. Eur. J. Cardio Thorac. Surg. 2019; 55: 876–884. DOI: 10.1093/ejcts/ezy372
  32. Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., et al. Percutaneous replacement of pulmonary valve in a right- ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000; 356: 1403–1405. DOI: 10.1016/S0140-6736(00)02844-0
  33. Troshkinev N.M., Tarasov R.S. Transcatheter pulmonary valve replacement for congenital heart defects. Russian Journal of Cardiology and Cardiovascular Surgery. 2023; 16 (2): 161–170 (in Russ.). DOI: 10.17116/kardio202316021161
  34. Svobodov A.A., Krylova A.S. Transcatheter pulmonary valve implantation: review of the valves approved for clinical application. Russian Journal of Cardiology and Cardiovascular Surgery. 2022; 15 (2): 144–150 (in Russ.). DOI: 10.17116/kardio202215021144
  35. Pursanov M.G. Endovascular transcatheter pulmonary valve replacement using balloon-expandable devices: a literature review. Complex Issues of Cardiovascular Diseases. 2024; 13 (4S): 197–207 (in Russ). DOI: 10.17802/2306-1278-2024-13-4S-197-207
  36. Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur. Heart J. 2019; 40 (27): 2255–2264. DOI: 10.1093/eurheartj/ehz201
  37. Egbe A.C., Salama A.A., Miranda W.R., Karnakoti S., Anderson J.H., Jain C.C. et al. Right heart reverse remodeling and prosthetic valve function after transcatheter vs surgical pulmonary valve replacement. JACC Cardiovasc. Interv. 2024; 17 (2): 248–258. DOI: 10.1016/j.jcin.2023.11.030

About Authors

  • Anton A. Lyapin, Cand. Med. Sci., Cardiovascular Surgeon; ORCID
  • Roman S. Tarasov, Dr. Med. Sci., Head of the laboratory of X-ray endovascular and reconstructive cardiovascular surgery; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by